GCC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.661600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.002200E-01
Normal-vs-Stage2
4.858400E-01
Normal-vs-Stage3
4.148100E-02
Normal-vs-Stage4
9.394400E-01
Stage1-vs-Stage2
5.234400E-01
Stage1-vs-Stage3
8.537700E-03
Stage1-vs-Stage4
7.978400E-01
Stage2-vs-Stage3
9.090200E-02
Stage2-vs-Stage4
3.495600E-01
Stage3-vs-Stage4
1.523450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.596200E-01
Normal-vs-AfricanAmerican
8.193200E-01
Normal-vs-Asian
3.246800E-01
Caucasian-vs-AfricanAmerican
5.207000E-01
Caucasian-vs-Asian
6.500000E-01
AfricanAmerican-vs-Asian
4.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.187600E-01
Normal-vs-Female
4.064800E-01
Male-vs-Female
7.892000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.991000E-01
Normal-vs-Age(41-60Yrs)
6.806800E-01
Normal-vs-Age(61-80Yrs)
3.928800E-01
Normal-vs-Age(81-100Yrs)
3.239800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.939400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.377800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.635000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.484200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.616800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.699800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.016800E-01
Normal-vs-Daily Drinker
2.621600E-01
Normal-vs-Weekly Drinker
7.067000E-01
Normal-vs-Occasional Drinker
2.751600E-01
Normal-vs-Social Drinker
8.421400E-01
Non Drinker-vs-Daily Drinker
7.995400E-01
Non Drinker-vs-Weekly Drinker
1.555240E-01
Non Drinker-vs-Occasional Drinker
3.239000E-01
Non Drinker-vs-Social Drinker
7.105600E-02
Daily Drinker-vs-Weekly Drinker
2.580200E-01
Daily Drinker-vs-Occasional Drinker
4.925600E-01
Daily Drinker-vs-Social Drinker
1.374370E-01
Weekly Drinker-vs-Occasional Drinker
5.052200E-01
Weekly Drinker-vs-Social Drinker
7.720200E-01
Occasional Drinker-vs-Social Drinker
2.971200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.731380E-01
Normal-vs-Grade 2
3.140300E-02
Normal-vs-Grade 3
5.402300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.456200E-01
Grade 1-vs-Grade 3
3.357400E-01
Grade 1-vs-Grade 4
1.731380E-01
Grade 2-vs-Grade 3
5.340400E-01
Grade 2-vs-Grade 4
3.140300E-02
Grade 3-vs-Grade 4
5.402300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.712200E-01
Normal-vs-NonDiabetic
3.979000E-01
Diabetic-vs-NonDiabetic
5.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.796200E-01
Normal-vs-NoPancreatitis
3.814800E-01
Pancreatitis-vs-NoPancreatitis
2.978400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.888600E-01
Normal-vs-N1
5.403800E-01
N0-vs-N1
3.017400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.694800E-01
Normal-vs-TP53-NonMutant
8.341600E-01
TP53-Mutant-vs-TP53-NonMutant
5.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
